Virios Therapeutics, Inc.
VIRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,127 | $13,403 | $17,539 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,529 | $1,301 | $1,625 | $0 |
| Total Curr. Assets | $11,655 | $14,704 | $19,164 | $0 |
| Property Plant & Equip (Net) | $189 | $207 | $210 | $0 |
| Goodwill | $12,210 | $12,458 | $11,823 | $0 |
| Intangibles | $67,920 | $69,304 | $65,770 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $19 | $19 | $18 | $0 |
| Total NC Assets | $80,337 | $81,988 | $77,821 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $91,993 | $96,693 | $96,985 | $0 |
| Liabilities | – | – | – | – |
| Payables | $585 | $498 | $1,154 | $0 |
| Short-Term Debt | $55 | $54 | $51 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,958 | $1,333 | $1,375 | $0 |
| Total Curr. Liab. | $2,597 | $1,885 | $2,580 | $0 |
| LT Debt | $120 | $132 | $141 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $11,890 | $12,134 | $11,515 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $12,011 | $12,267 | $11,656 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $175 | $187 | $191 | $0 |
| Total Liabilities | $14,608 | $14,152 | $14,236 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $70,127 | $75,662 | $75,662 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$104,296 | -$88,551 | -$84,744 | $0 |
| AOCI | -$1,636 | -$267 | -$3,802 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $7,258 | $6,879 | $7,087 | $0 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21,866 | $21,031 | $21,323 | $0 |
| Net Debt | -$9,952 | -$13,216 | -$17,348 | $0 |